Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Léaute-Labrèze C[au]:

Infantile haemangioma. Léauté-Labrèze C et al. Lancet. (2017)

Safety of Oral Propranolol for the Treatment of Infantile Hemangioma: A Systematic Review. Léaute-Labrèze C et al. Pediatrics. (2016)

A randomized, controlled trial of oral propranolol in infantile hemangioma. Léauté-Labrèze C et al. N Engl J Med. (2015)

Search results

Items: 1 to 50 of 141

1.

Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial.

Leducq S, Caille A, Barbarot S, Bénéton N, Bessis D, Boccara O, Bursztejn AC, Chiaverini C, Dompmartin A, Droitcourt C, Gissot V, Goga D, Guibaud L, Herbreteau D, Le Touze A, Léauté-Labrèze C, Lorette G, Mallet S, Martin L, Mazereeuw-Hautier J, Phan A, Plantin P, Quéré I, Vabres P, Bourgoin H, Giraudeau B, Maruani A; Groupe de Recherche de la Société Française de Dermatologie Pédiatrique.

Trials. 2019 Dec 17;20(1):739. doi: 10.1186/s13063-019-3767-8.

2.

Hereditary mucoepithelial dysplasia results from heterozygous variants at p.Arg557 mutational hotspot in SREBF1, encoding a transcription factor involved in cholesterol homeostasis.

Morice-Picard F, Michaud V, Lasseaux E, Rezvani HR, Plaisant C, Bessis D, Leauté-Labrèze C, Arveiler B, Taieb A, Trimouille A, Boralevi F.

J Invest Dermatol. 2019 Nov 29. pii: S0022-202X(19)33463-3. doi: 10.1016/j.jid.2019.10.014. [Epub ahead of print] No abstract available.

PMID:
31790666
3.

Allergic contact reaction to antiseptics in very young children.

Darrigade AS, Léauté-Labrèze C, Boralevi F, Taïeb A, Milpied B.

J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2284-2287. doi: 10.1111/jdv.15140. Epub 2018 Jul 31.

PMID:
29920802
4.

Propranolol pharmacokinetics in infants treated for Infantile Hemangiomas requiring systemic therapy: Modeling and dosing regimen recommendations.

Del Frari L, Léauté-Labrèze C, Guibaud L, Barbarot S, Lacour JP, Chaumont C, Delarue A, Voisard JJ, Brunner V.

Pharmacol Res Perspect. 2018 Apr 30;6(3):e00399. doi: 10.1002/prp2.399. eCollection 2018 Jun.

5.

[Benign aggressive vascular anomalies in children].

Boccara O, Maruani A, Léauté-Labrèze C.

Bull Cancer. 2018 Jun;105(6):610-625. doi: 10.1016/j.bulcan.2018.01.016. Epub 2018 Mar 20. French.

PMID:
29571951
6.

Lessons of a day hospital: Comprehensive assessment of patients with albinism in a European setting.

Marti A, Lasseaux E, Ezzedine K, Léauté-Labrèze C, Boralevi F, Paya C, Coste V, Deroissart V, Arveiler B, Taieb A, Morice-Picard F.

Pigment Cell Melanoma Res. 2018 Mar;31(2):318-329. doi: 10.1111/pcmr.12651. Epub 2017 Oct 21.

PMID:
28976636
7.

Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK Signaling.

Amyere M, Revencu N, Helaers R, Pairet E, Baselga E, Cordisco M, Chung W, Dubois J, Lacour JP, Martorell L, Mazereeuw-Hautier J, Pyeritz RE, Amor DJ, Bisdorff A, Blei F, Bombei H, Dompmartin A, Brooks D, Dupont J, González-Enseñat MA, Frieden I, Gérard M, Kvarnung M, Hanson-Kahn AK, Hudgins L, Léauté-Labrèze C, McCuaig C, Metry D, Parent P, Paul C, Petit F, Phan A, Quere I, Salhi A, Turner A, Vabres P, Vicente A, Wargon O, Watanabe S, Weibel L, Wilson A, Willing M, Mulliken JB, Boon LM, Vikkula M.

Circulation. 2017 Sep 12;136(11):1037-1048. doi: 10.1161/CIRCULATIONAHA.116.026886. Epub 2017 Jul 7.

PMID:
28687708
8.

High-dose pulsed corticosteroid therapy combined with methotrexate for severe alopecia areata of childhood.

Chong JH, Taïeb A, Morice-Picard F, Dutkiewicz AS, Léauté-Labrèze C, Boralevi F.

J Eur Acad Dermatol Venereol. 2017 Nov;31(11):e476-e477. doi: 10.1111/jdv.14291. Epub 2017 May 22. No abstract available.

PMID:
28426924
9.

Hemangiomas and cutaneous vascular malformations

Boccara O, Léauté-Labrèze C.

Rev Prat. 2017 Apr;67(4):e197-e204. French. No abstract available.

PMID:
30512902
10.

Genetics and vascular malformations

Boccara O, Léauté-Labrèze C.

Rev Prat. 2017 Apr;67(4):e196. French. No abstract available.

PMID:
30512901
11.

Infantile haemangioma.

Léauté-Labrèze C, Harper JI, Hoeger PH.

Lancet. 2017 Jul 1;390(10089):85-94. doi: 10.1016/S0140-6736(16)00645-0. Epub 2017 Jan 13. Review.

PMID:
28089471
12.

Red palms associated with adenovirus gastroenteritis.

Chong JH, Mermin D, Marti A, Lafon ME, Dutkiewicz AS, Léauté-Labrèze C, Boralevi F.

Arch Dis Child. 2017 Sep;102(9):868-869. doi: 10.1136/archdischild-2016-312107. Epub 2017 Jan 12. No abstract available.

PMID:
28082320
13.

Efficacy and safety of propranolol for epistaxis in hereditary haemorrhagic telangiectasia: retrospective, then prospective study, in a total of 21 patients.

Contis A, Gensous N, Viallard JF, Goizet C, Léauté-Labrèze C, Duffau P.

Clin Otolaryngol. 2017 Aug;42(4):911-917. doi: 10.1111/coa.12821. Epub 2017 Jan 20. No abstract available.

PMID:
28032956
14.

[What's new in pediatric dermatology?]

Léauté-Labrèze C.

Ann Dermatol Venereol. 2016 Dec;143 Suppl 3:S29-S36. doi: 10.1016/S0151-9638(18)30047-4. Review. French.

PMID:
29429507
15.

Safety of Oral Propranolol for the Treatment of Infantile Hemangioma: A Systematic Review.

Léaute-Labrèze C, Boccara O, Degrugillier-Chopinet C, Mazereeuw-Hautier J, Prey S, Lebbé G, Gautier S, Ortis V, Lafon M, Montagne A, Delarue A, Voisard JJ.

Pediatrics. 2016 Oct;138(4). pii: e20160353. Review.

16.

Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) Mutations.

Soblet J, Kangas J, Nätynki M, Mendola A, Helaers R, Uebelhoer M, Kaakinen M, Cordisco M, Dompmartin A, Enjolras O, Holden S, Irvine AD, Kangesu L, Léauté-Labrèze C, Lanoel A, Lokmic Z, Maas S, McAleer MA, Penington A, Rieu P, Syed S, van der Vleuten C, Watson R, Fishman SJ, Mulliken JB, Eklund L, Limaye N, Boon LM, Vikkula M.

J Invest Dermatol. 2017 Jan;137(1):207-216. doi: 10.1016/j.jid.2016.07.034. Epub 2016 Aug 9.

17.

KLICK syndrome: recognizable phenotype and hot-spot POMP mutation.

Morice-Picard F, Jonca N, Pichery M, Mermin D, Leauté-Labrèze C, Taïeb A, Mazereeuw-Hautier J, Boralevi F.

J Eur Acad Dermatol Venereol. 2017 Mar;31(3):e154-e156. doi: 10.1111/jdv.13898. Epub 2016 Aug 26. No abstract available.

PMID:
27503413
18.

Multifocal infantile haemangioma: a diagnostic challenge.

Torres E, Rosa J, Leaute-Labreze C, Soares-de-Almeida L.

BMJ Case Rep. 2016 Jun 17;2016. pii: bcr2016214827. doi: 10.1136/bcr-2016-214827.

19.

Skin Patterns Associated with Upper Airway Infantile Haemangiomas: A Retrospective Multicentre Study.

Uthurriague C, Boccara O, Catteau B, Fayoux P, Léauté-Labrèze C, Chiaverini C, Maruani A, Pondaven-Letourmy S, Alaidarous A, Puzenat E, Hubiche T, Mallet S, Dreyfus I, Mazereeuw-Hautier J.

Acta Derm Venereol. 2016 Nov 2;96(7):963-966. doi: 10.2340/00015555-2357.

20.

Safety of Propranolol Therapy for Severe Infantile Hemangioma.

Prey S, Voisard JJ, Delarue A, Lebbe G, Taïeb A, Leaute-Labreze C, Ezzedine K.

JAMA. 2016 Jan 26;315(4):413-5. doi: 10.1001/jama.2015.13969. No abstract available.

PMID:
26813215
21.

In Memoriam: Jean Maleville, 1927-2015.

Taïeb A, Léauté-Labrèze C.

Pediatr Dermatol. 2016 Jan-Feb;33(1):117-8. doi: 10.1111/pde.12720. Epub 2015 Dec 13. No abstract available.

PMID:
26663141
22.

Oral Propranolol for Infantile Hemangioma.

Léauté-Labrèze C, Voisard JJ, Moore N.

N Engl J Med. 2015 Jul 16;373(3):284-5. doi: 10.1056/NEJMc1503811. No abstract available.

PMID:
26176392
23.

Treatment of infantile haemangiomas: recommendations of a European expert group.

Hoeger PH, Harper JI, Baselga E, Bonnet D, Boon LM, Ciofi Degli Atti M, El Hachem M, Oranje AP, Rubin AT, Weibel L, Léauté-Labrèze C.

Eur J Pediatr. 2015 Jul;174(7):855-65. doi: 10.1007/s00431-015-2570-0. Epub 2015 May 29. Review.

PMID:
26021855
24.

Living with vitiligo: results from a national survey indicate differences between skin phototypes.

Ezzedine K, Grimes PE, Meurant JM, Seneschal J, Léauté-Labrèze C, Ballanger F, Jouary T, Taïeb C, Taïeb A.

Br J Dermatol. 2015 Aug;173(2):607-9. doi: 10.1111/bjd.13839. Epub 2015 Jul 28. No abstract available.

PMID:
25892476
25.

[Propranolol in infantile hemangiomas].

Léauté-Labrèze C.

Arch Pediatr. 2015 Apr;22(4):452-5. doi: 10.1016/j.arcped.2015.01.001. Epub 2015 Mar 6. French.

PMID:
25753275
26.

A randomized, controlled trial of oral propranolol in infantile hemangioma.

Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, Phillips RJ, Caceres H, Lopez Gutierrez JC, Ballona R, Friedlander SF, Powell J, Perek D, Metz B, Barbarot S, Maruani A, Szalai ZZ, Krol A, Boccara O, Foelster-Holst R, Febrer Bosch MI, Su J, Buckova H, Torrelo A, Cambazard F, Grantzow R, Wargon O, Wyrzykowski D, Roessler J, Bernabeu-Wittel J, Valencia AM, Przewratil P, Glick S, Pope E, Birchall N, Benjamin L, Mancini AJ, Vabres P, Souteyrand P, Frieden IJ, Berul CI, Mehta CR, Prey S, Boralevi F, Morgan CC, Heritier S, Delarue A, Voisard JJ.

N Engl J Med. 2015 Feb 19;372(8):735-46. doi: 10.1056/NEJMoa1404710.

27.

[Infantile hemangiomas: the revolution of beta-blockers].

Leaute-Labreze C.

Rev Prat. 2014 Dec;64(10):1421-8. French.

PMID:
25665327
28.

A prospective study of risk for Sturge-Weber syndrome in children with upper facial port-wine stain.

Dutkiewicz AS, Ezzedine K, Mazereeuw-Hautier J, Lacour JP, Barbarot S, Vabres P, Miquel J, Balguerie X, Martin L, Boralevi F, Bessou P, Chateil JF, Léauté-Labrèze C; Groupe de Recherche Clinique en Dermatologie Pédiatrique.

J Am Acad Dermatol. 2015 Mar;72(3):473-80. doi: 10.1016/j.jaad.2014.11.009. Epub 2015 Jan 13.

PMID:
25592619
29.

Stay in NICU and infantile haemangioma development.

Gey A, Ezzedine K, Diallo A, Prey S, Dreyfus I, Maza A, Mazereeuw-Hautier J, Taïeb A, Léauté-Labrèze C.

J Eur Acad Dermatol Venereol. 2015 Mar;29(3):566-73. doi: 10.1111/jdv.12639. Epub 2014 Aug 4.

PMID:
25088718
30.

Haemangioma family burden: creation of a specific questionnaire.

Boccara O, Méni C, Léauté-Labreze C, Bodemer C, Voisard JJ, Dufresne H, Brauchoux S, Taieb C.

Acta Derm Venereol. 2015 Jan;95(1):78-82. doi: 10.2340/00015555-1847.

31.

Mast cells as possible targets of propranolol therapy: an immunohistological study of beta-adrenergic receptors in infantile haemangiomas.

Prey S, Leaute-Labreze C, Pain C, Moisan F, Vergnes P, Loot M, Taieb A, Cario-Andre M.

Histopathology. 2014 Sep;65(3):436-9. doi: 10.1111/his.12421. Epub 2014 Jun 5. No abstract available.

PMID:
24666350
32.

Dermatological spectrum of hand, foot and mouth disease from classical to generalized exanthema.

Hubiche T, Schuffenecker I, Boralevi F, Léauté-Labrèze C, Bornebusch L, Chiaverini C, Phan A, Maruani A, Miquel J, Lafon ME, Lina B, Del Giudice P; Clinical Research Group of the French Society of Pediatric Dermatology Groupe de Recherche Clinique de la Société Française de Dermatologie Pédiatrique.

Pediatr Infect Dis J. 2014 Apr;33(4):e92-8. doi: 10.1097/INF.0000000000000120.

PMID:
24463804
33.

RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation.

Revencu N, Boon LM, Mendola A, Cordisco MR, Dubois J, Clapuyt P, Hammer F, Amor DJ, Irvine AD, Baselga E, Dompmartin A, Syed S, Martin-Santiago A, Ades L, Collins F, Smith J, Sandaradura S, Barrio VR, Burrows PE, Blei F, Cozzolino M, Brunetti-Pierri N, Vicente A, Abramowicz M, Désir J, Vilain C, Chung WK, Wilson A, Gardiner CA, Dwight Y, Lord DJ, Fishman L, Cytrynbaum C, Chamlin S, Ghali F, Gilaberte Y, Joss S, Boente Mdel C, Léauté-Labrèze C, Delrue MA, Bayliss S, Martorell L, González-Enseñat MA, Mazereeuw-Hautier J, O'Donnell B, Bessis D, Pyeritz RE, Salhi A, Tan OT, Wargon O, Mulliken JB, Vikkula M.

Hum Mutat. 2013 Dec;34(12):1632-41. doi: 10.1002/humu.22431. Epub 2013 Oct 10.

PMID:
24038909
34.

Diagnostic value of polymerase chain reaction analysis of skin biopsies in purpura fulminans.

Beau C, Vlassova N, Sarlangue J, Brissaud O, Léauté-Labrèze C, Boralevi F.

Pediatr Dermatol. 2013 Nov-Dec;30(6):e276-7. doi: 10.1111/pde.12181. Epub 2013 Jul 9.

PMID:
23834254
35.

Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol.

Ahogo CK, Ezzedine K, Prey S, Colona V, Diallo A, Boralevi F, Taïeb A, Léauté-Labrèze C.

Br J Dermatol. 2013 Dec;169(6):1252-6. doi: 10.1111/bjd.12432.

PMID:
23662995
36.

IFAG and childhood rosacea: a possible link?

Prey S, Ezzedine K, Mazereeuw-Hautier J, Eschard C, Barbarot S, Boralevi F, Taïeb A, Léaute-Labrèze C; Groupe de Recherche Clinique en Dermatologie Pédiatrique.

Pediatr Dermatol. 2013 Jul-Aug;30(4):429-32. doi: 10.1111/pde.12137. Epub 2013 Apr 8.

PMID:
23560522
37.

[Infantile hemangioma: update and treatment].

Léauté-Labrèze C.

Arch Pediatr. 2013 May;20(5):517-22. doi: 10.1016/j.arcped.2013.01.052. Epub 2013 Mar 6. Review. French.

PMID:
23474035
38.

Social isolation in parents of children with hemangiomas: effects of coping styles and emotional distress.

Quintard B, Gana K, Constant A, Quintric C, Taïeb A, Léauté-Labrèze C.

Psychol Health Med. 2013;18(6):698-704. doi: 10.1080/13548506.2013.766351. Epub 2013 Feb 6.

PMID:
23387298
39.

Double-blind randomized pilot trial evaluating the efficacy of oral propranolol on infantile haemangiomas in infants < 4 months of age.

Léauté-Labrèze C, Dumas de la Roque E, Nacka F, Abouelfath A, Grenier N, Rebola M, Ezzedine K, Moore N.

Br J Dermatol. 2013 Jul;169(1):181-3. doi: 10.1111/bjd.12217. No abstract available.

PMID:
23301692
40.

Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms.

Gey A, Diallo A, Seneschal J, Léauté-Labrèze C, Boralevi F, Jouary T, Taieb A, Ezzedine K.

Br J Dermatol. 2013 Apr;168(4):756-61. doi: 10.1111/bjd.12166.

PMID:
23253044
41.

Are post-vaccinal persistent itching nodules related to the use of local anaesthetic patches? A hypothesis to be confirmed.

Milpied B, Ezzedine K, Ohayon-Courtès C, Genillier-Foin N, Peyromat M, Taieb A, Léauté-Labrèze C.

Contact Dermatitis. 2012 Jun;66(6):343-4. doi: 10.1111/j.1600-0536.2012.02013.x. No abstract available.

PMID:
22568843
42.

Pre- vs. post-pubertal onset of vitiligo: multivariate analysis indicates atopic diathesis association in pre-pubertal onset vitiligo.

Ezzedine K, Diallo A, Léauté-Labrèze C, Seneschal J, Boniface K, Cario-André M, Prey S, Ballanger F, Boralevi F, Jouary T, Mossalayi D, Taieb A.

Br J Dermatol. 2012 Sep;167(3):490-5. doi: 10.1111/j.1365-2133.2012.11002.x.

PMID:
22512840
43.

Halo nevi association in nonsegmental vitiligo affects age at onset and depigmentation pattern.

Ezzedine K, Diallo A, Léauté-Labrèze C, Seneschal J, Mossalayi D, AlGhamdi K, Prey S, Bouchtnei S, Cario-André M, Boralevi F, Jouary T, Taieb A.

Arch Dermatol. 2012 Apr;148(4):497-502. doi: 10.1001/archdermatol.2011.351.

PMID:
22508876
44.

Topical timolol for small hemangiomas of infancy.

Moehrle M, Léauté-Labrèze C, Schmidt V, Röcken M, Poets CF, Goelz R.

Pediatr Dermatol. 2013 Mar-Apr;30(2):245-9. doi: 10.1111/j.1525-1470.2012.01723.x. Epub 2012 Apr 4.

PMID:
22471694
45.

Follicular vitiligo: a new form of vitiligo.

Ezzedine K, Amazan E, Séneschal J, Cario-André M, Léauté-Labrèze C, Vergier B, Boralevi F, Taieb A.

Pigment Cell Melanoma Res. 2012 Jul;25(4):527-9. doi: 10.1111/j.1755-148X.2012.00999.x. No abstract available.

PMID:
22417136
46.

First report of topical timolol treatment in primarily ulcerated perineal haemangioma.

Cante V, Pham-Ledard A, Imbert E, Ezzedine K, Léauté-Labrèze C.

Arch Dis Child Fetal Neonatal Ed. 2012 Mar;97(2):F155-6. doi: 10.1136/fetalneonatal-2011-301317. Epub 2011 Dec 21. No abstract available.

PMID:
22190187
47.

Successful treatment of intravascular papillary endothelial hyperplasia (IPEH) by the beta-adrenergic antagonist nebivolol.

Prey S, Haberstroh G, Vergier B, Taïeb A, Wassef M, Ezzedine K, Léauté-Labrèze C.

Br J Dermatol. 2012 May;166(5):1147-9. doi: 10.1111/j.1365-2133.2011.10755.x. No abstract available.

PMID:
22122809
48.

Halo naevi and leukotrichia are strong predictors of the passage to mixed vitiligo in a subgroup of segmental vitiligo.

Ezzedine K, Diallo A, Léauté-Labrèze C, Séneschal J, Prey S, Ballanger F, Alghamdi K, Cario-André M, Jouary T, Gauthier Y, Taieb A.

Br J Dermatol. 2012 Mar;166(3):539-44. doi: 10.1111/j.1365-2133.2011.10709.x.

PMID:
22032627
49.

[Metronidazole: alternative treatment for ocular and cutaneous rosacea in the pediatric population].

Léoni S, Mesplié N, Aitali F, Chamaillard M, Boralevi F, Marques da Costa C, Taïeb A, Léauté-Labrèze C, Colin J, Mortemousque B.

J Fr Ophtalmol. 2011 Dec;34(10):703-10. doi: 10.1016/j.jfo.2011.07.008. Epub 2011 Aug 31. French.

PMID:
21885154
50.

Efficacy of systemic propranolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients.

Thoumazet F, Léauté-Labrèze C, Colin J, Mortemousque B.

Br J Ophthalmol. 2012 Mar;96(3):370-4. doi: 10.1136/bjophthalmol-2011-300047. Epub 2011 Jun 14.

PMID:
21673014

Supplemental Content

Loading ...
Support Center